Document is current
Any future updates will be listed below
-
Authors
Saul, J.
Hutchins, E.
Reiman, R.
Saul, M.
Ostrow, L. W.
Harris, B. T.
Van Keuren-Jensen, K.
Bowser, R.
Bakkar, N. http://orcid.org/0000-0002-4656-9337
-
Funding
Funding for this research was provided by:
Amyotrophic Lateral Sclerosis Association (17-IIP-349)
Arizona Biomedical Research Commission (ADHS16-162412)
Barrow Neurological Foundation
- License Information
-
More Information
Article History
Received: 6 May 2020
Accepted: 15 June 2020
First Online: 26 June 2020
Ethics approval and consent to participate
: The postmortem tissue bank protocol and consent process were approved by the Dignity Health Institutional Review Board, and both the Target ALS and NIH Neurobiobank use IRB approved protocols and consents to collect and distribute tissue samples for research purposes.
: Not applicable.
: RB is a founder of Iron Horse Diagnostics, Inc., a biotechnology company focused on diagnostic and prognostic biomarkers for ALS and other neurologic disorders.
